Annual ROE
-38.16%
-27.93%-273.02%
December 31, 2023
Summary
- As of February 7, 2025, RPTX annual return on equity is -38.16%, with the most recent change of -27.93% (-273.02%) on December 31, 2023.
- During the last 3 years, RPTX annual ROE has risen by +6.22% (+14.02%).
- RPTX annual ROE is now -159.80% below its all-time high of 63.81%, reached on December 31, 2018.
Performance
RPTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-40.87%
-10.46%-34.40%
September 30, 2024
Summary
- As of February 7, 2025, RPTX quarterly return on equity is -40.87%, with the most recent change of -10.46% (-34.40%) on September 30, 2024.
- Over the past year, RPTX quarterly ROE has dropped by -3.84% (-10.37%).
- RPTX quarterly ROE is now -160.91% below its all-time high of 67.10%, reached on March 31, 2020.
Performance
RPTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RPTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -273.0% | -10.4% |
| 3 y3 years | +14.0% | -14.8% |
| 5 y5 years | -159.8% | - |
RPTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -273.0% | at low | -3363.6% | +23.5% |
| 5 y | 5-year | -164.7% | +14.0% | -160.9% | +29.4% |
| alltime | all time | -159.8% | +14.0% | -160.9% | +29.4% |
Repare Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -40.87%(+34.4%) |
| Jun 2024 | - | -30.41%(+56.3%) |
| Mar 2024 | - | -19.46%(-49.3%) |
| Dec 2023 | -38.16%(+273.0%) | -38.39%(+3.7%) |
| Sep 2023 | - | -37.03%(+3038.1%) |
| Jun 2023 | - | -1.18%(-89.3%) |
| Mar 2023 | - | -11.07%(+3.5%) |
| Dec 2022 | -10.23% | -10.70%(+8.1%) |
| Sep 2022 | - | -9.90%(-81.5%) |
| Jun 2022 | - | -53.41%(+13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -47.04%(+15.0%) |
| Dec 2021 | -37.17%(-16.2%) | -40.92%(+14.9%) |
| Sep 2021 | - | -35.60%(+27.6%) |
| Jun 2021 | - | -27.90%(+31.0%) |
| Mar 2021 | - | -21.30%(-15.9%) |
| Dec 2020 | -44.38%(-175.2%) | -25.34%(-30.5%) |
| Sep 2020 | - | -36.45%(-37.1%) |
| Jun 2020 | - | -57.91%(-186.3%) |
| Mar 2020 | - | 67.10%(+13.7%) |
| Dec 2019 | 59.00%(-7.5%) | 59.00% |
| Dec 2018 | 63.81% | - |
FAQ
- What is Repare Therapeutics annual return on equity?
- What is the all time high annual ROE for Repare Therapeutics?
- What is Repare Therapeutics annual ROE year-on-year change?
- What is Repare Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Repare Therapeutics?
- What is Repare Therapeutics quarterly ROE year-on-year change?
What is Repare Therapeutics annual return on equity?
The current annual ROE of RPTX is -38.16%
What is the all time high annual ROE for Repare Therapeutics?
Repare Therapeutics all-time high annual return on equity is 63.81%
What is Repare Therapeutics annual ROE year-on-year change?
Over the past year, RPTX annual return on equity has changed by -27.93% (-273.02%)
What is Repare Therapeutics quarterly return on equity?
The current quarterly ROE of RPTX is -40.87%
What is the all time high quarterly ROE for Repare Therapeutics?
Repare Therapeutics all-time high quarterly return on equity is 67.10%
What is Repare Therapeutics quarterly ROE year-on-year change?
Over the past year, RPTX quarterly return on equity has changed by -3.84% (-10.37%)